These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 25068805

  • 1. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
    Sun Y, Wang C, Yang H, Ma X.
    Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
    [Abstract] [Full Text] [Related]

  • 2. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X, Guo R, Qiao Y, Zhang Y, Lei J, Wang X, Li L, Hu D.
    Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
    [Abstract] [Full Text] [Related]

  • 3. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z, Qi S, Zhao X, Li M, Ding S, Lu J, Zhang H.
    Oncotarget; 2016 Apr 19; 7(16):21315-31. PubMed ID: 26824324
    [Abstract] [Full Text] [Related]

  • 4. Effect of AT1R knockdown on ishikawa cell proliferation induced by estrogen.
    Yang Q, Su Q, Wang G, Bi F, Sa R.
    Arch Gynecol Obstet; 2012 Aug 19; 286(2):481-7. PubMed ID: 22484478
    [Abstract] [Full Text] [Related]

  • 5. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y, Zhang Z, Liao H, Wu L, Wu X, Zhou D, Xi X, Zhu Y, Feng Y.
    Oncol Rep; 2012 Feb 19; 27(2):504-10. PubMed ID: 22075757
    [Abstract] [Full Text] [Related]

  • 6. Stromal cell-derived factor 1alpha stimulates human endometrial carcinoma cell growth through the activation of both extracellular signal-regulated kinase 1/2 and Akt.
    Zhao D, Li XP, Gao M, Zhao C, Wang JL, Wei LH.
    Gynecol Oncol; 2006 Dec 19; 103(3):932-7. PubMed ID: 16884765
    [Abstract] [Full Text] [Related]

  • 7. [Combined inhibition of PI3K and MEK has synergistic inhibitory effect on the proliferation of cisplatin-resistant ovarian cancer cells].
    Liu Y, Chen X, Luo Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun 19; 30(6):592-6. PubMed ID: 24909280
    [Abstract] [Full Text] [Related]

  • 8. The endocrine disruptor bisphenol A promotes nuclear ERRγ translocation, facilitating cell proliferation of Grade I endometrial cancer cells via EGF-dependent and EGF-independent pathways.
    Yaguchi T.
    Mol Cell Biochem; 2019 Feb 19; 452(1-2):41-50. PubMed ID: 30022450
    [Abstract] [Full Text] [Related]

  • 9. [Effects of PD98059 and LY294002 on subcutaneous xenograft of human endometrial carcinoma in nude mice].
    Guo RX, Zhang RF, Wang XY, Shi HR, Qiao YH.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jun 19; 46(6):446-52. PubMed ID: 21781587
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
    Bhowmik T, Gomes A.
    Chem Biol Interact; 2017 Apr 25; 268():119-128. PubMed ID: 28322778
    [Abstract] [Full Text] [Related]

  • 11. Visfatin stimulates endometrial cancer cell proliferation via activation of PI3K/Akt and MAPK/ERK1/2 signalling pathways.
    Wang Y, Gao C, Zhang Y, Gao J, Teng F, Tian W, Yang W, Yan Y, Xue F.
    Gynecol Oncol; 2016 Oct 25; 143(1):168-178. PubMed ID: 27473926
    [Abstract] [Full Text] [Related]

  • 12. ATX‑LPA axis facilitates estrogen‑induced endometrial cancer cell proliferation via MAPK/ERK signaling pathway.
    Zhang G, Cheng Y, Zhang Q, Li X, Zhou J, Wang J, Wei L.
    Mol Med Rep; 2018 Mar 25; 17(3):4245-4252. PubMed ID: 29328374
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 14. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP, Pezzuto JM.
    Cancer Res; 2001 Aug 15; 61(16):6137-44. PubMed ID: 11507064
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation.
    Shelton JG, Moye PW, Steelman LS, Blalock WL, Lee JT, Franklin RA, McMahon M, McCubrey JA.
    Leukemia; 2003 Sep 15; 17(9):1765-82. PubMed ID: 12970777
    [Abstract] [Full Text] [Related]

  • 16. Antiproliferative and apoptotic effect of epigallocatechin-3-gallate on Ishikawa cells is accompanied by sex steroid receptor downregulation.
    Park SB, Bae JW, Kim JM, Lee SG, Han M.
    Int J Mol Med; 2012 Nov 15; 30(5):1211-8. PubMed ID: 22923012
    [Abstract] [Full Text] [Related]

  • 17. [The role of ERK1/2 in leptin promoting the proliferation of human endometrial cancer cell line Ishikawa].
    Gong C, Liu Y, Xiao W, Yin J, Wang DH, Sheng H.
    Ai Zheng; 2007 Nov 15; 26(11):1211-4. PubMed ID: 17991320
    [Abstract] [Full Text] [Related]

  • 18. Nongenomic effect of estrogen on the MAPK signaling pathway and calcium influx in endometrial carcinoma cells.
    Zhang L, Li X, Zhao L, Zhang L, Zhang G, Wang J, Wei L.
    J Cell Biochem; 2009 Mar 01; 106(4):553-62. PubMed ID: 19160418
    [Abstract] [Full Text] [Related]

  • 19. Pseudolaric acid B induces endometrial cancer Ishikawa cell apoptosis and inhibits metastasis through AKT-GSK-3β and ERK1/2 signaling pathways.
    Wang D, Tian Y, Feng W, Zhao L, Zhao M, Liu J, Wang Q.
    Anticancer Drugs; 2017 Jul 01; 28(6):603-612. PubMed ID: 28422767
    [Abstract] [Full Text] [Related]

  • 20. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
    Dizeyi N, Hedlund P, Bjartell A, Tinzl M, Austild-Taskén K, Abrahamsson PA.
    Urol Oncol; 2011 Jul 01; 29(4):436-45. PubMed ID: 19926313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.